IRIS PubliCatt

Navarra, Pierluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.772
NA - Nord America 5.687
AS - Asia 1.185
SA - Sud America 24
OC - Oceania 14
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.695
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.640
DE - Germania 2.297
PL - Polonia 1.110
IT - Italia 942
SE - Svezia 849
CN - Cina 686
UA - Ucraina 473
FR - Francia 292
IE - Irlanda 244
GB - Regno Unito 230
SG - Singapore 228
IN - India 130
FI - Finlandia 108
RU - Federazione Russa 99
TR - Turchia 54
BE - Belgio 36
CA - Canada 29
NL - Olanda 19
MX - Messico 18
IR - Iran 17
VN - Vietnam 17
JP - Giappone 15
CZ - Repubblica Ceca 14
ES - Italia 14
AU - Australia 13
CH - Svizzera 13
HK - Hong Kong 11
BR - Brasile 10
CL - Cile 9
GR - Grecia 7
BG - Bulgaria 5
CI - Costa d'Avorio 5
KR - Corea 5
RO - Romania 5
IL - Israele 4
NO - Norvegia 4
DK - Danimarca 3
HU - Ungheria 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EU - Europa 2
GE - Georgia 2
IQ - Iraq 2
LT - Lituania 2
MN - Mongolia 2
MY - Malesia 2
PE - Perù 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
EG - Egitto 1
HR - Croazia 1
ID - Indonesia 1
KE - Kenya 1
MA - Marocco 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 13.695
Salva come PNG Salva come JPEG
Città #
Chandler 1.197
Warsaw 1.018
Ashburn 501
Jacksonville 317
San Mateo 274
Dublin 244
Fairfield 228
Verona 227
Wilmington 223
Nanjing 201
Houston 187
Ann Arbor 181
Woodbridge 157
New York 147
Nürnberg 144
Singapore 143
Cattolica 142
Seattle 132
Milan 131
Bremen 127
Dearborn 110
Rome 91
Kraków 88
Cambridge 87
Lawrence 85
Boston 82
Moscow 79
Munich 79
Nanchang 79
Marseille 76
Redwood City 63
Princeton 55
Chicago 54
Beijing 51
Izmir 47
Mountain View 43
Lancaster 38
Brussels 36
Hangzhou 35
Kunming 34
Boardman 33
Shenyang 32
University Park 32
Jiaxing 30
Leawood 29
Los Angeles 28
Fremont 27
Tianjin 25
Hebei 23
Pune 23
Changsha 21
Redmond 21
Philadelphia 20
Shanghai 19
Norwalk 18
San Diego 18
Zhengzhou 16
Dong Ket 14
London 14
Ottawa 13
Phoenix 13
Busto Arsizio 12
Guangzhou 12
Nutley 12
Augusta 11
Jinan 11
Falls Church 10
Hong Kong 10
Scottsdale 10
Washington 10
Costa Mesa 9
Detroit 9
Monmouth Junction 9
Naples 9
Simi Valley 9
Andover 8
Ferrara 8
Athens 7
Brno 7
Hefei 7
Helsinki 7
Indiana 7
Paris 7
Sydney 7
Toronto 7
Turin 7
Cagliari 6
Ciudad Nezahualcoyotl 6
Edinburgh 6
Florence 6
Kish 6
Lanzhou 6
Sandston 6
Abidjan 5
Amsterdam 5
Corchiano 5
Gustavo Adolfo Madero 5
Lappeenranta 5
Napoli 5
Pioltello 5
Totale 8.001
Salva come PNG Salva come JPEG
Nome #
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 351
mTOR kinase: a possible pharmacological target in the management of chronic pain 349
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 347
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 318
Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of BCL-XL gene expression. 304
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 304
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 303
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 300
The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon 257
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 194
The role of small intestinal bacterial overgrowth in Parkinson's disease 178
The human microglial HMC3 cell line: where do we stand? A systematic literature review 174
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 172
Effects of the administration of epidermal growth factor receptor specific inhibitor cetuximab, alone and in combination with cisplatin, on proliferation and apoptosis of Hep-2 laryngeal cancer cells 171
Full HTA di Emicizumab 168
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 154
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy 151
Effects of remifentanil on human C20 microglial pro-inflammatory activation 145
Buprenorphine inhibits bradykinin-induced release of calcitonin gene-related peptide from rat trigeminal neurons via both μ-opioid and nociceptin/orphanin peptide receptors. 138
Produzione in vitro e in vivo di interleuchina-1 dopo una convulsione febbrile 138
Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. 132
Antiretrovirals inhibit arginase in human microglia 126
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure 124
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 123
Variability of raltegravir plasma levels in the clinical setting 123
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 123
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 117
Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature 116
Stress-related biomarkers of dream recall and implicit memory under anaesthesia 116
Phospho-mTOR expression in human glioblastoma microglia-macrophage cells 116
Utilizzo degli antidepressivi e caratteristiche socio-economiche nelle regioni italiane. Evidenze da uno studio ecologico. 114
Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells 113
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy 113
N-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. 107
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 106
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction 106
Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro. 105
Validation of an UPLC-MS/MS Method for Quantitative Analysis of Raltegravir in Human Plasma Samples 105
Pro-inflammatory activation of a new immortalized human microglia cell line 104
The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis 103
Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis 102
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 101
Lacosamide inhibits calcitonin gene-related peptide production and release at trigeminal level in the rat 100
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 99
Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure. 98
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 98
Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin. 98
AMPA- and P2X7-receptor-mediated facilitation of [3H]D-aspartate release from nerve terminals isolated from the rat caudal brainstem. 98
Antiretrovirals inhibit arginase in human microglia 97
Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. 96
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception 96
Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study. 95
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: two years experience in routine clinical practice 93
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 92
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 92
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 91
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 90
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro 90
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 88
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment 87
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 86
Prolactin-lowering ability of (+/-)-idazoxan may be linked to a central noradrenergic-serotonergic interplay 85
Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection. 84
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception. 84
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 84
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 83
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 81
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 81
Correlation between algogenic effects of calcitonin-gene-related peptide (CGRP) and activation of trigeminal vascular system, in an in vivo experimental model of nitroglycerin-induced sensitization 81
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 81
Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients 80
Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature. 79
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells 79
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 78
Exploiting microglial functions for the treatment of glioblastoma 78
beta-Carotene Downregulates the Steady-State and Heregulin-{alpha}-Induced COX-2 Pathways in Colon Cancer Cells. 76
A dual effect of some 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon 76
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 76
Molecular and pharmacological evidence for a facilitatory functional role of presynaptic GLUK2/3 kainate receptors on GABA release in rat trigeminal caudal nucleus. 76
Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation 75
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 74
Flupirtine antinociception in the rat orofacial formalin test: an analysis of combination therapies with morphine and tramadol. 74
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 74
Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients 72
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 72
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis 71
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm 71
Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary-adrenal axis. 70
Exploiting Microglial Functions for the Treatment of Glioblastoma 69
Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages 69
Diffusion of complementary evolving pharmaceutical innovations: The case of Abacavir and its pharmacogenetic companion diagnostic in Italy 68
Pharmacokinetic profile of Oncofid-S after intraperitoneal and intravenous administration in the rat. 67
P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals 66
The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. 64
Death to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature. 64
Influence of the Oral Dissolution Time on the Absorption Rate of Locally Administered Solid Formulations for Oromucosal Use: The Flurbiprofen Lozenges Paradigm 64
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells 64
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials 64
Interactions between Integrase Inhibitors and human Arginase 1 63
Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer. 61
Totale 11.773
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.692 0 0 194 227 137 164 194 99 185 106 243 143
2020/20211.436 77 157 24 151 171 74 216 34 188 99 204 41
2021/20221.711 149 112 26 102 120 64 42 235 72 96 429 264
2022/20233.106 356 452 241 520 243 367 115 271 345 48 93 55
2023/20241.630 89 396 66 153 82 219 118 54 30 57 182 184
2024/2025188 77 87 24 0 0 0 0 0 0 0 0 0
Totale 13.893